UBS Group AG (UBS)
UBS Group to Miss Workforce Reduction Goal Post CS Takeover
UBS is falling behind its plan to cut headcount to 85,000 by 2026 as Credit Suisse integration slows workforce reductions.
Gold Miners Are Crushing Gold: UBS Says Grab These 5 Cheap Picks
In 2025, gold-mining stocks are generally outperforming the price of gold, driven by high gold prices and improved operational efficiencies.
Gold market strength boosts equities as UBS sees room for more gains
Gold mining stocks have surged in 2025, outpacing bullion as strong quarterly results and disciplined capital spending help restore investor confidence, UBS said. The GDX index has risen more than 40% year-to-date and outperformed gold by 15% over the past three months, led by Gold Fields (+40%), AngloGold Ashanti (+30%), Newmont (+30%) and Kinross (+25%).
UBS Group Touches 52-Week High: Should You Buy the Stock Now?
UBS hits a 52-week high on strong Q2 results, Credit Suisse integration gains, and solid capital position despite expense concerns.
BT Group is still a ‘sell' - UBS
UBS has repeated a ‘Sell' rating for BT Group PLC (LSE:BT.A) with analysts recasting concerns over heightened competition from ‘altnet' broadband providers in the UK. Pitched at 135p, the bank's price target sees downside of around 36% from the prevailing share price of 212p.
Kinross Gold a ‘Buy' on valuation upside and cash returns, UBS says
Kinross Gold Corporation (TSX:K) has earned a ‘Buy' rating from UBS analysts in their initial coverage, along with a US$20 per share price target. Shares of Kinross added almost 5% on the news, trading hands at US$18 on Tuesday afternoon.
UBS to Pay $300M to Settle Credit Suisse Mortgage Securities Lawsuit
UBS is set to pay $300M to settle a U.S. DOJ case over Credit Suisse's mortgage securities mis-selling, closing a key legacy legal issue.
Gold remains 'attractive' as investment demand surges, says top bank
UBS has reaffirmed its positive stance on gold, rating the metal as “attractive” even as prices sit near all-time highs. The precious metal has outperformed all other asset classes in 2025, rising 29% since the start of the year, comfortably ahead of equities, bonds and even bitcoin, according to UBS strategists.
Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to competition from compounding as well as arch rival Eli Lilly, a brokerage said on Tuesday.
UBS settles legacy Credit Suisse US mortgage-backed securities case
UBS Group AG (NYSE:UBS) has reached a settlement with the US Department of Justice over a longstanding issue linked to Credit Suisse's former residential mortgage-backed securities (RMBS) business. Under the agreement, Credit Suisse Securities (USA) will pay USD 300 million to fulfil all remaining consumer relief obligations set out in a 2017 settlement.
UBS Group Q2 Earnings & Revenues Rise Y/Y, Expenses Decline
UBS posted a $2.39B Q2 profit, boosted by Wealth and Investment Bank gains, while costs fell and Credit Suisse integration advanced.
UBS (UBS) Beats Q2 Earnings and Revenue Estimates
UBS (UBS) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to earnings of $0.34 per share a year ago.
